Immunomodulating effect of low density lipoprotein on human monocytes

Area of Science:

• Immunology
• Cell Biology
• Biochemistry

Background:

• Low-density lipoprotein (LDL) is a key factor in cardiovascular health.
• Monocytes play a crucial role in immune responses and inflammation.
• Dysfunctional monocytes are implicated in the pathogenesis of atherosclerosis.

Purpose of the Study:

• To investigate the in vitro effects of LDL on human monocyte function.
• To elucidate the molecular mechanisms underlying LDL-induced monocyte activation and inhibition.
• To explore the potential role of LDL-mediated monocyte responses in arteriosclerosis.

Main Methods:

• Isolation of LDL from healthy volunteer sera.
• Incubation of human monocytes with varying concentrations of LDL.
• Measurement of adenylate cyclase activity, cGMP levels, and 45Ca2+ influx.
• Assay of oxygen consumption, hydrogen peroxide generation, and lysosomal enzyme release (beta-glucuronidase, elastase-like protease).
• Evaluation of Fc gamma receptor-mediated functions (rosette formation, phagocytosis, ADCC) and IgG binding.

Main Results:

• LDL induced early adenylate cyclase activation and elevated cGMP levels in monocytes.
• LDL triggered rapid 45Ca2+ influx and enhanced O2 consumption, H2O2 generation, and lysosomal enzyme release.
• LDL significantly inhibited Fc gamma receptor-mediated rosette formation, phagocytosis, and ADCC.
• LDL did not significantly decrease the IgG binding capability of monocytes.

Conclusions:

• LDL exerts dual effects on human monocytes, promoting activation and impairing key immune functions.
• LDL-induced release of elastase-like protease and reactive oxygen species may contribute to arterial wall injury.
• These findings suggest a significant role for high serum LDL levels in the pathogenesis of arteriosclerosis.